Form 4 holding
Director
Theravance Biopharma, Inc.
- Security class
- Ordinary Shares
- Shares / value
- 97,213
- Estimated value
- $1,577,766
- Report date
- 12 Jun 2026
- Price
- $16.23
- Ownership
- Direct
Dean J. Mitchell - Director at Theravance Biopharma, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- TBPH on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Dean J. Mitchell since 20 Sep 2025
Reported holdings for Dean J. Mitchell in Theravance Biopharma, Inc.
Form 4 holding
Director
Theravance Biopharma, Inc.
- Security class
- Share Option (Right to Buy)
- Shares / value
- 13,398
- Estimated value
- Report date
- 12 Jun 2026
- Price
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
Transaction history for Dean J. Mitchell in Theravance Biopharma, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.